About Tezepelumab
Class: | Monoclonal antibody (anti-IL-33)
Use: | Indicated for the treatment of severe asthma in patients aged 12 years and older, particularly those with an eosinophilic phenotype or oral corticosteroid-dependent asthma.
Adult dose: | 210 mg administered subcutaneously once every 4 weeks.
Pediatric dose: | Safety and efficacy have not been established in pediatric patients under 12 years of age.
Side effects: | Common side effects include injection site reactions, headache, pharyngitis,
Drug Class
Monoclonal antibody (anti-IL-33)
Uses & Indications
Indicated for the treatment of severe asthma in patients aged 12 years and older, particularly those with an eosinophilic phenotype or oral corticosteroid-dependent asthma.
Storage Requirements
Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Can be kept at room temperature (up to 25°C or 77°F) for a maximum of 14 days.
Manufacturer & Packaging
Manufacturer: AstraZeneca AB. [Sodertalje;Sweden], Sweden
Package Size
1 Single-dose Pre-filled Pen
Price & Supplier
Price in UAE: AED 7431.50
Dosage Information
Adult Dose
210 mg administered subcutaneously once every 4 weeks.
Pediatric Dose
Safety and efficacy have not been established in pediatric patients under 12 years of age.
Side Effects
Common side effects include injection site reactions, headache, pharyngitis, and arthralgia.
Contraindications & Precautions
Hypersensitivity to tezepelumab or any component of the formulation.
Important Warnings
Risk of hypersensitivity reactions; monitor for signs of anaphylaxis. Not indicated for the treatment of acute asthma symptoms or exacerbations.
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.